Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jul 2 2023 | HFSA President's Update: July 2023 HFSA News President's Updates Read More Jul 1 2023 | Heart Failure Awareness 365: Pregnancy and Heart Failure Patient News Heart Failure Awareness 365 Patient Resource Read More Jun 24 2023 | New Episode of the Heart Failure Beat Explores Coronary Revascularization in Ischemic Heart Failure HFSA News Podcasts Provider Education Read More Jun 22 2023 | Cytokinetics Announces Start of MAPLE-HCM, a Phase 3 Clinical Trial of Aficamten Compared to Metoprolol in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Industry News In The News Industry Read More Jun 16 2023 | U.S. Food and Drug Administration Approves Addition of Positive Data from Phase 3 VALOR-HCM Study to CAMZYOS® (mavacamten) Label Industry News In The News Industry Read More Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Jul 1 2023 | Heart Failure Awareness 365: Pregnancy and Heart Failure Patient News Heart Failure Awareness 365 Patient Resource Read More
Jun 24 2023 | New Episode of the Heart Failure Beat Explores Coronary Revascularization in Ischemic Heart Failure HFSA News Podcasts Provider Education Read More
Jun 22 2023 | Cytokinetics Announces Start of MAPLE-HCM, a Phase 3 Clinical Trial of Aficamten Compared to Metoprolol in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Industry News In The News Industry Read More
Jun 16 2023 | U.S. Food and Drug Administration Approves Addition of Positive Data from Phase 3 VALOR-HCM Study to CAMZYOS® (mavacamten) Label Industry News In The News Industry Read More
